A Computational Exploration of the Interactions of the Green Tea Polyphenol (-)-Epigallocatechin 3-Gallate with Cardiac Muscle Troponin C

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Botten, Dominic ^a   Fugallo, Giorgia ^a   Fraternali, Franca ^b   Molteni, Carla ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; EPIGALLOCATECHIN GALLATE; TROPONIN C; TROPONIN I;

ARTICLE; BINDING AFFINITY; BINDING SITE; CALCIUM BINDING; CALCULATION; CONTROLLED STUDY; DRUG PROTEIN BINDING; ELECTROCARDIOGRAM; HEART MUSCLE; HYDROGEN BOND; HYDROPHOBICITY; LIGAND BINDING; MOLECULAR DYNAMICS; PROTEIN FUNCTION; SIMULATION; TEA;

BINDING SITES; CALCIUM; CATECHIN; HUMANS; HYDROGEN BONDING; MODELS, MOLECULAR; MOLECULAR CONFORMATION; MYOCARDIAL CONTRACTION; MYOCARDIUM; POLYPHENOLS; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; TEA; TROPONIN C;

EID: 84880852474     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070556     Document Type: Article

References (56)

1. Hamza A, Zhan C, (2006) How can (-)-epigallocatechin gallate from green tea prevent HIV-1 infection? J Phys Chem B 110: 2910-2917.
2. Yamaguci A, Honda M, Ikigai H, Hara Y, Shimamura T, (2002) Inhibitory effects of (-)-epigallocatechin gallate on the life cycle of human immunodeficiency virus type 1 (HIV-1). Antiviral Research 53: 19-34.
3. Nakayama M, Suzuki K, Toda M, Okubo S, Hara Y, et al. (1993) Inhibition of the infectivity of inuenza virus by tea polyphenols. Antiviral Research 21: 289-299.
4. Ehrnhoefer DE, Bieschke J, Boeddrich A, Herbst M, Masino L, et al. (2008) EGCg redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers. Nat Struct Mol Biol 15: 558-566.
5. Bieschke J, Russ J, Friedrich RP, Ehrnhoefer DE, Wobst H, et al. (2010) EGCg remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity. Proc Natl Acad Sci U S A 107: 7710-7715.
6. Hertog M, Feskens E, Hollman P, Katan M, Kromhout D, (1992) Dietary antioxidant avonoids and risk of coronary heart disease: the zutphen elderly study. Lancet 339: 1523-1526.
7. Riemersma R, Rice-Evans C, Tyrrell R, Clifford M, Lean M, (2001) Tea avonoids and cardiovascular health. Q J Med 94: 277.
8. Hodgson M, (2008) Tea avonoids and cardiovascular disease. Asia Pac J Clin Nutr 17: 288-290.
9. Rathore K, Choudhary S, Odoi A, Wang HCR, (2012) Green tea catechin intervention of reactive oxygen species-mediated ERK pathway activation and chronically induced breast cell carcinogenesis. J Carcinog 33: 174-183.
10. Kostin SF, McDonald DE, McFadden DW, (2012) Inhibitory effects of (-)-epigallocatechin-3-gallate and pterostilbene on pancreatic cancer growth in vitro. J Surg Res 177: 255-262.
11. Singh BN, Shankar S, Srivastava RK, (2011) Green tea catechin, epigallocatechin-3-gallate (EGCg): Mechanisms, perspectives and clinical applications. Biochem Pharm 82: 1807-1821.
12. Tadano N, Du C, Yumoto F, Morimoto S, Ohta M, et al. (2010) Biological actions of green tea catechins on cardiac troponin C. Br J Pharmacol. 161: 1034-1043.
13. Robertson I, Li M, Sykes B, (2009) Solution structure of human cardiac troponin C in complex with the green tea polyphenol, (-)-epigallocatechin 3-gallate. J Biol Chem 284: 23012-23022.
14. Wong WW, Gerson JH, Rubenstein PA, Reisler E, (2002) Thin filament regulation and ionic interactions between the N-terminal region in actin and troponin. Biophys J 83: 2726-2732.
15. Parmacek MS, Solaro RJ, (2004) Biology of the troponin complex in cardiac myocytes. Prog Cardiovasc Dis 47: 159-176.
16. Gomes AV, Potter JD, Szczesna-Cordary D, (2002) The role of troponins in muscle contraction. IUBMB Life 54: 323-333.
17. Sia S, Li M, Spyracopoulos L, Gagne S, Liu W, et al. (1997) Structure of cardiac muscle troponin C unexpectedly reveals a closed regulatory domain. J Biol Chem 272: 18216-18221.
18. Takeda S, Yamashita A, Maeda K, Maeda Y, (2003) Structure of the core domain of human cardiac troponin in the Ca2+ saturated form. Nature 424: 35-41.
19. Spyracopoulos L, Li M, Sia S, Gagne S, Chandra M, et al. (1997) Calcium-induced structural transition in the regulatory domain of human cardiac troponin C. Biochemistry. 36: 12138-12146.
20. Kekenes-Huskey PM, Lindert S, McCammon JA, (2012) Molecular basis of calcium-sensitizing and desensitizing mutations of the human cardiac troponin c regulatory domain: A multi-scale simulation study. PLoS Computational Biology 8: e1002777.
21. Lindert S, Kekenes-Huskey PM, Huber G, Pierce L, McCammon JA, (2012) Dynamics and Calcium Association to the N-Terminal Regulatory Domain of Human Cardiac Troponin C: A Multiscale Computational Study. J Phys Chem B 116: 8449-8459.
22. Mercier P, Li M, Sykes B, (2000) Role of the structural domain of troponin C in muscle regulation: NMR studies of Ca2+ binding and subsequent interactions with regions 1-40 and 96-115 of troponin I. Biochemistry. 39: 2902-2911.
23. Yanaga F, Morimoto S, Ohtsuki I, (1999) Ca2+ sensitization and potentiation of the maximum level of myofibrillar atpase activity caused by mutations of troponin T found in familial hypertrophic cardiomyopathy. J Biol Chem 274: 8806-8812.
24. Baryshnikova OK, Robertson IM, Mercier P, Sykes BD, (2008) The dilated cardiomyopathy G159D mutation in cardiac troponin C weakens the anchoring interaction with troponin I. Biochemistry. 47: 10950-10960.
25. Li M, Spyracopoulos L, Beier N, Putkey J, Sykes B, (2000) Interaction of cardiac troponin C with Ca2+ sensitizer EMD 57033 and cardiac troponin I inhibitory peptide. Biochemistry 39: 8782-8790.
26. Laio A, Parrinello M, (2002) Escaping free energy minima. Proc Natl Acad Sci U S A 99: 12562-12566.
27. Laio A, Gervasio FL, (2008) Metadynamics: a method to simulate rare events and reconstruct the free energy in biophysics, chemistry and material science. Rep Prog Phys 71: 126601.
28. Singh U, Kollman P, (1984) An approach to computing electrostatic charges for molecules. J Comput Chem 5: 129-145.
29. Becke AD, (1988) Density-functional exchange-energy approximation with correct asymptotic-behavior. Phys Rev A 38: 3098-3100.
30. Lee C, Yang W, Parr RG, (1988) Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. Phys Rev B 37: 785-789.
31. Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, et al. (2004) Gaussian 03 revision c.02. Technical report, Gaussian, Inc., Wallingford, CT.
32. Morris G, Goodsell D, Halliday R, Huey R, Hart W, et al. (1998) Automated docking using a lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem 19: 1639-1662.
33. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, et al. (2000) The protein data bank. Nucleic Acids Res 28: 235-242.
34. Case D, Darden T, T Cheatham I, Simmerling C, Wang J, et al. (2008) AMBER 10. University of California, San Francisco.
35. Case D, Cheatham T, Darden T, Gohlke H, Luo R, et al. (2005) The Amber biomolecular simulation programs. J Comput Chem 26: 1668-1688.
36. Ponder J, Case D (2003) Force fields for Protein Simulations. In: Protein Simulations, 525 B Street, Suite 1900, San Diego, CA 92101-4495 USA: Academic Press Inc., volume 66 of Advances in Protein Chemistry. 27+.
37. Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML, (1983) Comparison of simple potential functions for simulating liquid water. J Chem Phys 79: 926-935.
38. Ryckaert J, Ciccotti G, Berendsen H, (1977) Numerical integration of the cartesian equations of motion of a system with constraints: Molecular dynamics of n-alkanes. J Comput Phys 23: 327-341.
39. Berendsen H, Postma J, van Gunsteren W, DiNola A, Haak J, (1984) Molecular dynamics with coupling to an external bath. J Chem Phys 81: 3684-3690.
40. Senzaki H, Isoda T, Paolocci N, Ekelund U, Hare J, et al. (2000) Improved mechanoenergetics and cardiac rest and reserve function of in vivo failing heart by calcium sensitizer EMD-57033. Circulation 101: 1040-1048.
41. Miller BR, McGee TD, Swails JM, Homeyer N, Gohlke H, et al. (2012) MMPBSA.py: An efficient program for end-state free energy calculations. J Chem Theory Comput 8: 3314-3321.
42. Hou T, Wang J, Li Y, (2011) WangW (2011) Assessing the performance of the MM/PBSA and MM/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations. J Chem Info Model 51: 69-82.
43. Moreira IS, Fernandes PA, Ramos MJ, (2007) Computational alanine scanning mutagenesisan improved methodological approach. J Comput Chem 28: 644-654.
44. Chong LT, Pitera JW, Swope WC, Pande VS, (2009) Comparison of computational approaches for predicting the effects of missense mutations on p53 function. J Mol Graphics Model 27: 978-982.
45. Brice AR, Dominy BN, (2011) Analyzing the robustness of the MM/PBSA free energy calculation method: Application to DNA conformational transitions. J Comput Chem 32: 1431-1440.
46. Kollman PA, Massova I, Reyes C, Kuhn B, Huo S, et al. (2000) Calculating structures and free energies of complex molecules: Combining molecular mechanics and continuum models. Acc Chem Res 33: 889-897.
47. Levy R, Zhang L, Gallicchio E, Felts A, (2003) On the nonpolar hydration free energy of proteins: Surface area and continuum solvent models for the solute-solvent interaction energy. J Am Chem Soc 125: 9523-9530.
48. Singh N, Warshel A, (2010) Absolute binding free energy calculations: On the accuracy of computational scoring of protein-ligand interactions. Proteins 78: 1705-1723.
49. Barducci A, Bussi G, Parrinello M, (2008) Well-tempered metadynamics: A smoothly converging and tunable free-energy method. Phys Rev Lett 100: 020603.
50. Bonomi M, Branduardi D, Bussi G, Camilloni C, Provasi D, et al. (2009) PLUMED: A portable plugin for free-energy calculations with molecular dynamics. Comput Phys Commun 180: 1961-1972.
51. Dweck D, Reynaldo DP, Pinto JR, Potter JD, (2010) A dilated cardiomyopathy troponin C mutation lowers contractile force by reducing strong myosin-actin binding. J Biol Chem 285: 17371-17379.
52. Dong WJ, Xing J, Ouyang Y, An J, Cheung HC, (2008) Structural kinetics of cardiac troponin C mutants linked to familial hypertrophic and dilated cardiomyopathy in troponin complexes. J Biol Chem 283: 3424-3432.
53. Robinson P, Griffiths PJ, Watkins H, Redwood CS, (2007) Dilated and hypertrophic cardiomyopathy mutations in troponin and alpha-tropomyosin have opposing effects on the calcium affinity of cardiac thin filaments. Circ Res 101: 1266-1273.
54. Liu B, Tikunova SB, Kline KP, Siddiqui JK, Davis JP, (2012) Disease-related cardiac troponins alter thin filament Ca2+ association and dissociation rates. PLoS ONE 7: e38259.
55. Liou YM, Kuo SC, Hsieh SR, (2008) Differential effects of a green tea-derived polyphenol (-)-epigallocatechin-3-gallate on the acidosis-induced decrease in the Ca2+ sensitivity of cardiac and skeletal muscle. Pugers Arch, EJP 456: 787-800.
56. Lindhout D, Boyko R, Corson D, Li M, Sykes B, (2005) The role of electrostatics in the interaction of the inhibitory region of troponin I with troponin C. Biochemistry. 44: 14750-14759.